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Abstract 35 
Staphylococcus aureus is a major human pathogen causing infections with high morbidity and 36 
mortality in both healthcare and community settings. The accessory gene regulator (Agr) is a key 37 
genetic element controlling the expression of numerous virulence factors in S. aureus. The 38 
significance of a functional Agr system in clinical S. aureus isolates derived from pediatric wound 39 
infections is still unclear. Therefore, the present study was conducted to identify virulence genes 40 
and determine Agr functionality from this cohort of patients. A total of 48 S. aureus wound isolates 41 
were collected from patients referred to Tehran Children's Medical Center Hospital from April 42 
2017 to April 2018. In addition, in vitro antimicrobial susceptibility of the isolates was assessed 43 
using the disk diffusion and E-test methods. Conventional PCR was performed for the detection 44 
of toxins (tsst-1, hla, hlb, hld, eta, etb, etd, edin-A, edin-B, edin-C) and Agr typing (agrI, agrII, 45 
agrIII, agrIV). Agr functionality was assessed by quantitative reverse transcriptase real-time PCR 46 
(qRT-PCR). All S. aureus isolates were found to be susceptible to linezolid and vancomycin. The 47 
most frequently detected toxin gene was eta (100%), and the most prevalent Agr type was agrIII 48 
(56.3%). Importantly, qRT-PCR revealed that Agr was functional in 28 (58%) of wound isolates. 49 
Consequently, our data suggests that a functional Agr system may not be required for the 50 
development of S. aureus wound infections.  51 
 52 
Keywords: Staphylococcus aureus, Agr functionality, wound infections, pediatrics.  53 
 54 
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1. Introduction 66 
Staphylococcus aureus is an ever-present opportunistic pathogen that can cause a variety of 67 
diseases. The severity of S. aureus-associated infections ranges from benign localized skin 68 
abscesses to life-threatening diseases, such as arthritis, osteomyelitis, and endocarditis (Francois 69 
et al., 2006; von Eiff et al., 2004). In recent decades, methicillin-resistant S. aureus (MRSA) strains 70 
have emerged as a predominant cause of invasive diseases, namely skin and soft tissues, as well 71 
as musculoskeletal infections in children (Kaushik and Kest, 2018). This bacterium is one of the 72 
most dominant commensals on human skin and nasal mucosa and can express a multitude of 73 
virulence factors, such as surface adhesins, enterotoxins and hemolysins which are central in the 74 
development of disease. (Kassam et al., 2017; Stevens et al., 2017). The synchronized expression 75 
of these virulence determinants is tightly controlled by the cumulative action of several regulatory 76 
elements, such as the accessory gene regulator (agr), staphylococcal accessory regulator A (sarA), 77 
and the alternative sigma factor B (σB) (Manna and Cheung, 2001). 78 
 79 
The Agr system plays a central role in the growth-phase dependent modulation of virulence 80 
gene expression (Bronner et al., 2004; Sakoulas et al., 2003a). The agr operon is an autocatalytic 81 
system controlled in a cell density-dependent fashion through the production and sensing of auto-82 
inducing peptides (AIP). At high cell density, the Agr system increases the production of many 83 
secreted virulence factors, including Toxic shock syndrome toxin -1 (TSST-1), delta-hemolysin 84 
and exfoliative toxins A and B (ETA and ETB). In contrast, Agr decreases the expression of several 85 
colonization factors such as fibronectin binding proteins, important in adhesion and biofilm 86 
formation (Li et al., 2018). The agr locus consists of two distinct transcripts, RNAII and RNAIII, 87 
which are transcribed by two promoters, P2 and P3 respectively. The activation of P2 induces the 88 
expression of the components involved in cell-to-cell quorum-sensing communication 89 
(AgrBDCA) (Bibalan et al., 2014a). Both AgrB and AgrD function to process and secrete the auto-90 
inducing peptide (AIP), which acts as the chemical messenger critical for Agr activity (Wang et 91 
al., 2014). Upon reaching a critical density, AIPs interact with the sensor kinase, AgrC which 92 
promotes phosphorylation of the DNA binding response regulator AgrA. Phosphorylated AgrA 93 
undergoes a conformational change permitting interaction and binding to the intergenic region 94 
between P2 and P3 facilitating their expression.  P3 activation leads to the expression of RNAIII, 95 
the effector of target gene regulation (Novick and Geisinger, 2008). 96 
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Several studies have demonstrated a correlation between agr types and particular diseases. For 97 
example phylogenetic group AF1 (agr group IV) strains are closely related to generalized 98 
exfoliative syndromes and bullous impetigo whereas endocarditis is mainly caused by 99 
phylogenetic group AF2 (agr groups II and I) strains (Jarraud et al., 2002). In addition, it has been 100  
suggested that agr group III and IV strains are associated with toxic shock syndrome (Gomes et 101  
al., 2005). To the best of our knowledge, there is no published study evaluating Agr functionality 102  
among Iranian S. aureus isolates. The present study was conducted to determine dominant Agr 103  
types, Agr activity and presence of specific virulence genes in S. aureus isolates derived from 104  
pediatric wound infections. 105  
 106  
2.1 Materials and Methods 107  
2.1 Bacterial isolation and identification 108  
In the present study, 48 S. aureus isolates were collected from wound infections of pediatric 109  
patients referred to the Children's Medical Center Hospital Tehran, Iran over one year from April 110  
2017-2018. The School of Medicine, Shahid Beheshti University of Medical Sciences ethics 111  
committee approved this study (IR.SBMU.MSP.REC.1395.369). The isolates were identified as 112  
S. aureus according to phenotypic (colonial morphology and Gram-stain), biochemical (catalase, 113  
haemolysis, oxidase, coagulase, DNase, and mannitol fermentation tests) and genetic (polymerase 114  
chain reaction (PCR) detection of S. aureus specific nuclease A (nucA) gene) analysis. The isolates 115  
were stored in Tryptic Soy Broth (TSB) (Merck, Germany) containing 20% glycerol at -80C for 116  
further investigation.  117  
 118  
2.2 Antimicrobial susceptibility testing 119  
Antibiotic susceptibility testing was performed using the Kirby-Bauer disc-diffusion method as 120  
recommended by the Clinical and Laboratory Standards Institute (CLSI) (Huse et al., 2017). 121  
Commercially available antibiotic disks (Mast Co., UK) used in this study included penicillin (10 122  
units), ciprofloxacin (5 μg), clindamycin (2 mg), gentamicin (10 μg), erythromycin (15 μg), 123  
linezolid (30 μg), oxacillin (30 μg), trimethoprim-sulfamethoxazole (1.25/23.75 μg) and 124  
ceftaroline (30 μg). In addition, susceptibility to vancomycin was determined using minimum 125  
inhibitory concentration (MIC) E-test strips (Liofilchem Co., Roseto, Italy). 126  
2.3 MRSA identification 127  
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For detection of MRSA isolates, an MIC of cefoxitin was determined using E-test (Liofilchem 128  
Co., Italy). S. aureus ATCC 25923 was used as a quality control reference strain. Additionally, for 129  
the molecular detection of MRSA, PCR analysis of the mecA gene was performed (Table 1).  130  
 131  
2.4 DNA extraction 132  
Genomic DNA was isolated from bacterial strains grown in Mueller-Hinton broth (Merck Co., 133  
Germany) overnight at 37°C. Pelleted bacterial cells were resuspended in 200 μl of phosphate-134  
buffered saline (PBS) and then DNA extraction was carried out using High Pure PCR Template 135  
Preparation Kit (Roche Co., Germany) according to the manufacturer’s instructions. Evaluation of 136  
the concentration and purity of extracted DNA was measured by Nanodrop (DeNovix Inc., USA). 137  
Extracted DNA was stored at -20°C for later analysis.  138  
 139  
2.5 Molecular detection of toxin genes and Agr typing 140  
The presence of the virulence genes encoding toxins, (tsst-1, hla, hlb, hld, eta, etb, etd, edin-A, 141  
edin-B, and edin-C) were investigated using PCR. The product size and annealing temperature of 142  
each primer sets are provided in Table 1. Agr typing was conducted using a pan forward primer 143  
and four specific reverse primers (Table 1). The PCR reaction was performed in a total volume of 144  
25 μl containing 12.5 μl of 2X master mix (BIOFACT, Korea), 1μl (10 pM/ µl) of each primer, 145  
8.5 μl of distilled water, and 2μl of DNA (10 ng) template. The cycling programs, was preceded 146  
by 4 min at 94° C and consisted of 30 cycles of 94° C for 2 min, 1 min annealing at specific 147  
temperature for each primer set (Table 1) and 72° C for 1 min, followed by a final extension step 148  
at 72° C for 5 min. PCR amplicons were separate using 1.2% agarose gels and visualized by 149  
staining with gel red stain (CinnaGen Co., Iran). 150  
 151  
2.6 Reverse transcription and quantitative RT-PCR 152  
S. aureus isolates grown overnight in TSB were diluted 1:1000 in fresh TSB and grown at 37°C 153  
for 6 h. The cultures were treated with two volumes of RNAlater (Sigma-Aldrich, Germany), 154  
immediately mixed by gentle vortexing for 5 s and incubated for 10 min at room temperature. 155  
Next, cultures were centrifuged at 7000 × g for 10 min, supernatant discarded and the resulting 156  
pellet was stored at -70°C until required.  Following thawing on ice, the pellet was resuspended in 157  
Tris-EDTA (TE) buffer (pH 8) containing 200 µg/mL lysozyme (Sigma-Aldrich Co., Germany) 158  
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and 250 μg/mL lysostaphin (Sigma-Aldrich Co., Germany) followed by incubation at 37°C for 2 159  
h. During the incubation period, the suspension was mixed for 10s in 10 min intervals. Following 160  
incubation, the suspension was treated with proteinase K (Roche Co., Germany) for 20 min at 161  
37°C with mixing for 10 s at 3 min intervals. RNA extraction was performed using the RNeasy 162  
Mini Kit (Roche Co., Germany) according to the manufacturer's instructions with the addition of 163  
an extra DNase treatment (CinnaGen Co., Iran) following RNA purification. The absence of DNA 164  
contamination was verified by PCR amplification of the housekeeping gyrA gene. Reverse 165  
transcription was carried out using the cDNA synthesis kit (Wizbio Co., South Korea) according 166  
to the manufacturer's instructions. Real-time PCR was performed with SYBR green PCR master 167  
mix (Amplicon Co., Denmark) using specific primers for both gyrA [gyrAF: 5’-168  
CCAGGTAAATTAGCCGATTGC-3’; gyrAR: 5’-AAATCGCCTGCGTTCTAGAG-3’] and 169  
RNAIII [rnaIIIF:5’-GAAGGAGTGATTTCAATGGCACAAG-3’, rnaIIIR: 5’-170  
GAAAGTAATTAATTATTCATCTTATTTTTTAGTGAATTTG-3’]. Cycling conditions were 171  
95°C for 10 min followed by 40 cycles of 95°C for 20 s and 54°C for 1 min and a dissociation step 172  
72°C for 20 s. The relative expression was normalized to the value of the positive control (S. aureus 173  
strain NCTC8325) as described previously (Gomes-Fernandes et al., 2017a). Accordingly, Agr 174  
functionality was determined as RNAIII expression of within 10-fold of the positive control as 175  
described previously (Gomes-Fernandes et al., 2017a).  Experiments were performed using three 176  
biological replicates.  177  
 178  
2.7 Statistical analysis  179  
The data was analyzed with SPSS version 22.0 (IBM Corp., USA). Gene expression analysis was 180  
performed using REST® 2009 (Qiagen, Germany) software. Independent-samples t-test was used 181  
to evaluate differences between test groups. A p-value of less than 0.05 was considered statistically 182  
significant. 183  
 184  
 185  
 186  
 187  
 188  
 189  
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3. Results 190  
3.1 Bacterial strains and antimicrobial resistance profiles 191  
In this study, 48 S. aureus clinical isolates were collected from pediatric wound infections from 192  
children aged between 1 day and 14 years. 14 (29.2%) samples were collected from patients 193  
admitted to the in infectious disease ward, 9 (18.8%) from post-surgery ward, 15 (31.2%) from 194  
infants, 6 (12.5%) from OPD, 3 (6.3%) from in-patient ward, 2 (4.2%) from emergency cases, and 195  
3 (6.3%) from gastrointestinal, 2 (4.2%) from neurosurgery, 2 (4.2%) from intensive care unit, 1 196  
(2.1%) from coronary intensive care unit and1 (2.1%) from nephrology wards. The antibiotic 197  
susceptibility profile showed that all isolates were susceptible to linezolid and vancomycin. 198  
Clinical isolates were highly susceptible to ceftaroline (89.6%, n=43), trimethoprim-199  
sulfamethoxazole (83.3%, n=40), and gentamicin (77.1%, n=37). Lastly, the susceptibility rate for 200  
ciprofloxacin, cefoxitin, erythromycin, and penicillin was determined 68.8% (n=33), 43.8% 201  
(n=21), 39.6% (n=19), and 2.1% (n=1), respectively (Table 2). The frequency of MRSA and 202  
MSSA were 57.6% and 43.7%, respectively based on both cefoxitin susceptibility and presence of 203  
mecA gene.  204  
 205  
3.2 Distribution of toxin-encoding genes  206  
We evaluated the prevalence of S. aureus toxin-encoding genes from strains isolated from pediatric 207  
wound infections using PCR and primers outlined in Table 1. Additionally, the resultant amplicons 208  
generated were sequenced and submitted to GENBANK, and the accession numbers for tsst-1, eta, 209  
etb, and edin-C genes are shown in Table 4. Our results showed that the eta was the most prevalent 210  
gene (100%), followed by hld (97.9%), hla (72.9%), hlb (60.4%), edin-B (47.9%), tsst (41.7%), 211  
edin-C (33.3%), etd (22.9%), etb (14.6%), edin-A (2.1%). Based on statistical analysis, there was 212  
no significant correlation between antibiotics resistance and toxins genes in MRSA and MSSA 213  
isolates (Table 3).  214  
 215  
3.3 Agr typing  216  
Agr type were determined by PCR using specific primers (Table 1). Generated PCR amplicons 217  
were sequenced and submitted to GENBANK with the accession numbers of agrII, agrIII shown 218  
in Table 4. The results indicate that agrIII gene (56.3%) was the predominant Agr type followed 219  
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by agrI (41.7%), agrII (8.3%), and agrIV (8.3%). Statistical analysis of virulence genes and Agr 220  
type indicated no significant association. 221  
 222  
3.4 Agr functionality evaluation  223  
In order to measure Agr activity, RNAIII expression was evaluated and compared with S. aureus 224  
strain NCTC8325 as a control. In total 48 wound isolates of S. aureus were assessed. Figure 1 225  
illustrates the expression level of RNAIII among MRSA (Fig 1a) and MSSA (Fig 1b) isolates 226  
using qRT-PCR. Agr functionality was observed in 28 (58%) wound isolates with 56% of MRSA 227  
(15/27) and 61% of MSSA (13/21) being classed as Agr functional.  We observed a significant 228  
correlation between the presence of tsst-1 gene with Agr functionality (p=0.05). However no 229  
statistically significant association was observed between Agr functionality and the presence of 230  
toxin genes, methicillin resistance or Agr class type.  231  
 232  
4. Discussion 233  
The present study was conducted to evaluate the activity of the Agr system among clinical isolates 234  
of S. aureus derived from pediatric wound infections. In addition, the association between Agr 235  
activity and the presence of several virulence determinants and antibiotic susceptibility was 236  
examined. Several techniques can be used to determine Agr function including the CAMP 237  
synergistic haemolysis assay, the Vesicle Lysis Test (VLT) and qRT-PCR detection of RNAIII.  238  
Agr activity is traditionally evaluated using the CAMP test, which reports on the expression of 239  
delta haemolysin, a 26-amino acid toxin translated from the rnaIII transcript (Novick and 240  
Geisinger, 2008). A previous study reported that the interpretation of the CAMP test for evaluation 241  
of Agr activity may be unreliable with results varying between different laboratories, particularly 242  
observed for S. aureus strains exhibiting weak haemolytic activity (Traber et al., 2008). 243  
Alternatively it is shown that the VLT method, a highly sensitive assay specific to toxins strictly 244  
regulated by Agr system, is more reliable than CAMP assay for Agr functionality assessment 245  
(Laabei et al., 2014).  However, the evaluation of RNAIII expression using qRT-PCR is still 246  
considered the gold-standard for Agr activity assessment (Gomes-Fernandes et al., 2017b; Laabei 247  
et al., 2014). Accordingly, we investigated the expression of RNAIII as a marker for Agr activity 248  
using qRT-PCR in our cohort of S aureus strains.  249  
 250  
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 Our results demonstrated that 58% of tested S. aureus isolates were Agr functional. The 251  
expression of virulence genes by S. aureus is influenced by the Agr system, which controls the 252  
balance of virulence factors known to be important during the  colonization and invasive phases 253  
of infection (Papakyriacou et al., 2000). To the best of our knowledge, there are no published 254  
studies examining Agr functionality among clinical isolates of S. aureus derived from pediatric 255  
wound infections. A recent study reported that Agr activity was high (82.2%) in S. aureus strains 256  
isolated from lower respiratory tract infections (Gomes-Fernandes et al., 2017b). These findings 257  
suggest the importance of a functional Agr system in lower respiratory tract colonization and 258  
infection. In contrast, previous work has highlighted that genes encoding the Agr system are down-259  
regulated in cases of persistent bacteremia (Malachowa et al., 2011). However, a recent review of 260  
numerous studies highlighted that the percentage of Agr dysfunctional strains isolated from 261  
bacteraemia varies widely (3-82%) (Painter et al., 2014). This most likely reflects the different 262  
methods in testing Agr and different genetic backgrounds of S aureus strains. Different infections 263  
may promote the emergence of Agr dysfunction. It has also been demonstrated that apolipoproteins 264  
in human blood can interfere and inhibit Agr activity (Reuter et al., 2016) whereas this selection 265  
for downregulating Agr function may not be as strong in other infections.  266  
 267  
The Agr typing results revealed that the majority of isolates belonged to Agr Group III followed 268  
by Agr Group I, Agr Group II, and Agr Group IV. In accordance with our data, two recent studies 269  
highlighted that Agr Group III was the predominate Agr group derived from hospital clinical 270  
isolates (Bibalan et al., 2014b) (Ben Ayed et al., 2006). The exact relationship between specific 271  
Agr groups and particular infections is not clear, however past studies have highlighted significant 272  
associations between the two factors. For instance, past work reported that the majority of 273  
menstrual toxic shock strains belonged to Agr specificity Group III and exfoliative toxin producers 274  
responsible for staphylococcal scalded skin syndrome (SSSS) and bullous impetigo were 275  
designated Agr Group IV (Jarraud et al., 2000). Furthermore, it was observed that TSST-1 276  
producing strains belonged to agr Groups I and III (Chini et al., 2006). Additionally, isolates taken 277  
from patients suffering from endocarditis were mainly associated with with agr Group I (Gomes 278  
et al., 2005). Finally in a study investigating Agr activity in bloodstream isolates it was reported 279  
that more than half of strains belonged to agr group II (Sakoulas et al., 2003b). Our analysis 280  
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showed that there was no significant correlation between Agr types and S. aureus isolates from 281  
wound infection however the majority of isolates belonged to Agr group III.  282  
 283  
Previous studies have focused on examining the relationship between Agr functionality and 284  
susceptibility to some antimicrobial agents. The most prominent observations highlighted a 285  
reduction in vancomycin susceptibility in Agr dysfunctional isolates (Soon et al., 2017; Tsuji et 286  
al., 2012; Tsuji et al., 2007). In this study, we observed no association between antibiotic resistance 287  
and Agr dysfunction. One limitation of this study was the relatively low sample size of isolates 288  
tested. Additionally, we did not screen for nasal carriage nor genotype the .S aureus isolates. These 289  
additionally tests would indicate whether the infecting S. aureus isolate was part of the patient’s 290  
microflora or had been introduced externally from the hospital environment. Future studies will 291  
incorporate these analyses and improve our understating of S. aureus wound infections.  292  
 293  
5. Conclusion  294  
In the present study, the data revealed that there was no significant correlation between Agr 295  
activity and the ability to cause wound infections by S. aureus strains. 296  
 297  
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Target Sequences(5ꞌ-3ꞌ) Annealing 
temperature 
(C°) 
Product 
size 
(bp) 
Reference 
nuc 
 
mecA  
 
 
F: GCGATTGATGGTGATACGGTT 54 
 
60 
 
270 
 
310 
(Stuhlmeier and 
Stuhlmeier, 2003) 
 
 
(Seni et al., 2013) 
R: AGCCAAGCCTTGACGAACTAAAGC 
F: GTAGAAATGACTGAACGTCCGATAA 
R CCAATTCCACATTGTTTCGCTCTAA 
 
tsst-1 F: TTATCGTAAGCCCTTTTGTTG                              46 398 (Benvidi et al., 2017) 
R: TAAAGGTAGTTCTATTGGAGTAGG 
hla F: CTGATTACTATCCAAGAAATTCGATTG 53 210 (Suryadevara et al., 
2012) 
R: CTTTCCAGCCTACTTTTTTATCAGT                                                                                                                                          
hlb F: GTGCACTTACTGACAATAGTGC 53 310 (Suryadevara et al., 
2012) 
R: GTTGATGAGTAGCTACCTTCAGT 
Hld F: GAATTTGTTCACTGTGTCG                                      49 357 (Kiran et al., 2009) 
R: TTTACACCACTCTCCTCAC 
eta F: TTTGCTTTCTTGATTTGGATTC 51 464 (Koosha et al., 2014) 
R: GATGTGTTCGGTTTGATTGAC 
etb F: ACGGCTATATACATTCAATT 51 226 (Suryadevara et al., 
2012) 
R: TCCATCGATAATATACCTAA 
etd F:GGGGAGACTATAGCTTCTGGTGTATTA 55.5 477 (Franke et al., 2010) 
R: TCCAACATGAATACCAACTAACTCT         
edinA F: TAAATGGGGGAATAAACTTA 43 248 (Yamashita et al., 
2013) 
R: CGATACTTGTCAAATAATCT 
edinB F: CATAAATACTCCTCTAAG    40 444 (Ohkura et al., 2009) 
R: GCATATTCTGTCCCTCTA 
edinC F: TATTAAGCATTCATTCAA 45 629 (Ohkura et al., 2009) 
R: AGTGTAGTCTGTTCCTCT 
agr 
 
 
Pan F: ATGCACATGGTGCACATGC  -  
(Suryadevara et al., 
2012) 
 
 
R1: GTCACAAGTACTATAAGCTGCGAT                                54.5 
54 
439 
573 R2: TATTACTAATTGAAAAGTGCCATAGC                              
R3: GTAATGTAATAGCTTGTATAATAATACCCAG 54.5 
56 
406 
657 R4: CGTAATGCCGTAATACCCG 
 442  
 443  
 444  
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Table 2. The antimicrobial susceptibility patterns of S. aureus isolated from wound infection of 445  
pediatric patients 446  
 447  
Antibiotics (%) Resistance (%)Intermediate (%) Susceptible 
Penicillin  (97.9%)  0  (2.1%) 
Erythromycin  (45.8%)  (14.6%)  (39.6%) 
Clindamycin  (41.7%)  (12.5%)  (45.8%) 
Cefoxitin  (56.3%)  0  (43.8%) 
trimethoprim-
sulfamethoxazole 
 (16.7%)  0  (83.3%) 
Oxacillin (54.2%) 0 (45.8%) 
Linezolid 0 0 (100%) 
gentamicin (22.9%) 0 (77.1%) 
ceftaroline (8.3%) (2.1%)  (89.6%) 
ciprofloxacin (27.1%) (3.4%) (69.5%) 
vancomycin 0 0 (100%) 
 448  
 449  
 450  
 451  
 452  
 453  
 454  
 455  
 456  
 457  
 458  
 459  
 460  
 461  
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Table 3. The frequency of the virulence and Agr genes determinant among the MRSA and MSSA 462  
isolated in S. aureus  463  
* value P  
 
MSSA 
 
 
 
 
MRSA 
 
 
gene 
0.771 38.09% 37.28% tsst-1 
0.338 80.9% 66.6% hla 
0.380 52.38% 66.6% hlb 
0.438 95.23% 100% hld 
1 100% 100% eta 
0.118 23.8% 7% etb 
0.733 19.04% 25.92% etd 
1 0% 3.7% edinA 
0.383 57.14% 40.7% edinB 
0.237 42.85% 25.92% edinC 
1 42.85% 40.74% agrI 
1 9.5% 7.4% agrII 
0.144 42.85% 66.6% agrIII 
1 9.5% 7.4% agrIV 
* p values were measured using a Chi-squared analysis 464  
 465  
 466  
 467  
 468  
 469  
 470  
 471  
 472  
 473  
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Table 4. Accession numbers of genes 474  
Target gene Accession Numbers 
tsst-1 MH805860 
eta,  MH727607 
etb MH818223 
edin-C MH750913 
agrII MH805858 
agrIII MH805859 
 475  
 476  
 477  
 478  
 479  
 480  
 481  
 482  
 483  
 484  
 485  
 486  
 487  
 488  
 489  
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 490  
 491  
Figure 1. The expression level of RNAIII among MRSA (A) and MSSA (B) strains.  492  
27 MRSA (A) and 21 MSSA (B) isolates were analyzed for Agr activity using qRT-PCR. Fold change of 493  
RNAIII expression was normalized to the housekeeping gene gyrB. The red line depicts the cut off for 494  
functional Agr activity based on a 10-fold difference to a positive Agr control.   495  
 496  
A B 
